<DOC>
	<DOCNO>NCT01250899</DOCNO>
	<brief_summary>This research study look vitamin D deficiency ( low level ) men woman HIV . As part regular medical care , screen vitamin D deficiency . If level low , choose start use vitamin D supplement , investigator would like take blood start use vitamin D see affect level HIV , T cell , cholesterol , blood level . The investigator provide vitamin D supplement first 24 week ( 6 month ) study . If physician decide continue take vitamin D supplement time , responsible purchasing vitamin D supplement .</brief_summary>
	<brief_title>Vitamin D HIV-Infected Patients HAART</brief_title>
	<detailed_description />
	<mesh_term>Vitamin D Deficiency</mesh_term>
	<mesh_term>Vitamins</mesh_term>
	<mesh_term>Vitamin D</mesh_term>
	<mesh_term>Ergocalciferols</mesh_term>
	<criteria>HIVpositive men woman age 18 older . HIV1 RNA document &lt; 200 copies/mL current ART regimen , support viral load documentation 24 week prior study entry . Subjects must receive primary HIV care UCLA CARE center . Subjects must undergo screen vitamin D deficiency primary care provider time study entry , undergone vitamin D screen 90 day prior consent without yet initiate vitamin D supplementation ( insufficient subject ) . Ability willingness subject provide inform consent Use vitamin D supplementation ( include 400 IU daily , amount standard multivitamin ) time screen . HIVinfected subject ART . HIVinfected subject suppress current ART regimen ( HIV1 RNA &gt; 200 copies/mL 6 month prior screen ) .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>90 Years</maximum_age>
	<verification_date>November 2014</verification_date>
	<keyword>HIV</keyword>
	<keyword>Vitamin D</keyword>
	<keyword>HAART</keyword>
</DOC>